Design and operation of a current good manufacturing practices cell-engineering laboratory

ISSN： 1465-3249

Source： Cytotherapy, Vol.2, Iss.2, 2000-02, pp. : 111-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current good manufacturing practices: application to the processing of hematopoietic cell components

By Rowley S.

Cytotherapy, Vol. 2, Iss. 1, 2000-01 ,pp. : 59-62

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Good manufacturing practices (GMP) in a hospital environment: the ideal and the real

By Donnenberg A D

Cytotherapy, Vol. 3, Iss. 2, 2001-03 ,pp. : 63-65

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy

By Tam Yk Martinson Ja Doligosa K Klingemann H-g

Cytotherapy, Vol. 5, Iss. 3, 2003-01 ,pp. : 259-272

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy

By Tam Yk Martinson Ja Doligosa K Klingemann H-g

Cytotherapy, Vol. 5, Iss. 2, 2003-01 ,pp. : 259-272

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Current translational and clinical practices in hematopoietic cell and gene therapy

By Digiusto David L. Kiem Hans-Peter

Cytotherapy, Vol. 14, Iss. 7, 2012-08 ,pp. : 775-790

Ashgate Publishing Ltd

Access to resources Recommend Favorite